Frank Chen
Chairman of the Board
Mr. Chen is currently serving as Vice General Manager, Investment Management and Special Assistant to Chairman of Ruentex Group.
He obtained his Master’s degree in Business Administration from National Taiwan University.
Jeng Her
Director
Dr. Jeng Her is the founder and CEO of AP Biosciences. He had received a bachelor’s degree in Physics from the National Taiwan University, then turned into biology and earned a Ph.D. degree in Microbiology and Immunology from the University of Virginia in 1993.
Before setting up AP Biosciences in Taiwan, he had co-founded KaloBios Pharmaceuticals in the Silicon Valley soon after his post-doctoral training at Bristol-Myers Squibb and DNAX Research Institute (now part of Merck). At KaloBios, he co-invented the antibody Humaneering™, a technology which converts non-human antibodies into engineered human-like antibodies with sequences close to the germline to minimize immunogenicity. The technology was then licensed to Novartis non-exclusively for $32M. In 2013, KaloBios went public on NASDAQ with three antibodies in clinical trials, including KB001 for ventilator-associated pneumonia, which was licensed to Sanofi-Pasteur for $270 million.
Su-Ming Lin
Independent Director
Ph.D., Arizona State University (Accounting)
Associate Dean, College of Management, NT
Independent Director of Chunghwa Telecom Co., Ltd.
Independent Director of Taiwan Fertilizer Co., Ltd.
Commissioner of the Appeals Review Committee, Taipei City Government
Commissioner of the Reformation of Taxation Committee, Executive Yuan
Consultant of Certified Public Accountant, ROC
Lai-Sho Su
Independent Director
Master of Business Administration, University of North Texas, USA
Independent Director, ScinoPharm Taiwan, Ltd.
Independent Director, Synmosa Biopharma Corporation
Executive Secretary, National Development Fund, Executive Yuan
Anya Lin
Independent Director
Ph.D. in Pharmacology, Colorado State University, USA
Professor, School of Pharmacy, National Yang Ming Chiao Tung University / Acting Director, Institute of Food Safety and Health Risk Assessment
Dean, College of Pharmaceutical Sciences and Founding Chair, School of Pharmacy, National Yang Ming Chiao Tung University
Director, Institute of Pharmacology, National Yang Ming University
Researcher, Department of Medical Research, Taipei Veterans General Hospital
Ya-Chi,Chen
Director
Ph.D. in Pharmacy, University of Iowa, USA
Senior Director, Clinical Pharmacology Gilead Sciences, Foster City
Executive Director, Clinical Pharmacology Revolution Medicines, Redwood City
Principal Scientist, Genentech Inc., South San Francisco
Wan-Fang Ting
Director
Master of Business Administration in International Finance ,National Taipei University
Master of Biotechnology, University of Queensland, Australia
Associate Researcher, Board of Science and Technology, Executive Yuan
Associate Researcher, Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute (ITRI)
Finance Manager, Investment Management Department of Ruentex Group
